Menopausal transition, mood, and cognition: An integrated view to close the gaps

Menopause

Volumn 17, Issue 4, 2010, Pages 812-814

  Soares, Claudio N ^a   Maki, Pauline M ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cognition; Depression; Estrogen; Hormone therapies; Hormone therapy; Menopausal hormone therapy; Menopausal transition; Mood; Perimenopause

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTROGEN; GESTAGEN;

AGING; ANXIETY DISORDER; CARDIOVASCULAR DISEASE; CLIMACTERIUM; COGNITION; COGNITIVE DEFECT; DEPRESSION; DRUG EFFICACY; DRUG FORMULATION; HORMONAL THERAPY; HUMAN; LIFESTYLE; MENTAL STRESS; MOOD; MOOD DISORDER; OVARIECTOMY; RISK FACTOR; SEXUALITY; SHORT SURVEY; WOMEN'S HEALTH; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; FEMALE; HORMONE SUBSTITUTION; LIFE EVENT; MENOPAUSE; MOOD DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

CARDIOVASCULAR DISEASES; COGNITION DISORDERS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE CHANGE EVENTS; MENOPAUSE; MOOD DISORDERS; RISK FACTORS;

EID: 77954913420     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181de0943     Document Type: Short Survey

References (19)

1. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 2008;33:331-343.
2. Santoro N, Neal-Perry G. Normal aging and the menopausal transition: what to expect. In: Soares CN, Warren M, eds. The Menopausal Transi-tion: Interface Between Psychiatry and Gynecology. Basel, Switzerland: Karger AG, 1-17.
3. Frey BN, Lord C, Soares CN. Depression during menopausal transi-tion: a review of treatment strategies and pathophysiological correlates. Menopause Int 2008;14:123-128.
4. Greendale GA, Huang MH, Wight RG, et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 2009;72:1850-1857.
5. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2006;63:385-390.
6. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hor-mones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-382.
7. Wildman RP, Colvin AB, Powell LH, et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008;15: 414-421.
8. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovas-cular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009;54:2366-2373.
9. Hodis HN, Mack WJ. Postmenopausal hormone therapy and cardiovas-cular disease in perspective. Clin Obstet Gynecol 2008;51:564-580.
10. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since meno-pause. JAMA 2007;297:1465-1477.
11. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo controlled trial. Arch Gen Psychiatry 2001; 58:529-534.
12. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183:414-420.
13. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004;55:406-412.
14. Maki PM, Rubin LH, Fornelli D, et al. Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause 2009;16:1167-1177.
15. Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 2007;69:1322-1330.
16. Resnick SM, Maki PM, Rapp SR, et al; Women's Health Initiative Study of Cognitive Aging Investigators. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006;91:1802-1810.
17. Rocca WA, Grossardt BR, Geda YE, et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 2008;15:1050-1059.
18. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cogni-tive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083.
19. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Pre-mature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161-166.